Neena Kadaba
Directeur/Bestuurslid bij Eyevensys SAS
Actieve functies van Neena Kadaba
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Directeur/Bestuurslid | 08-01-2020 | - |
Loopbaan van Neena Kadaba
Eerdere bekende functies van Neena Kadaba
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01-01-2011 | 31-12-2015 |
Opleiding van Neena Kadaba
| Massachusetts Institute of Technology | Graduate Degree |
| California Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Frankrijk | 2 |
Operationeel
| Private Equity Investor | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Finance | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
- Beurs
- Insiders
- Neena Kadaba
- Ervaring
